Skip to content
Thursday 27 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,878.12
-0.07%
DAX
26,285.96
0.00%
CAC 40
8,462.39
0.00%
STOXX 50
6,470.74
0.00%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE

Businesswire

  • Fourth Launches iQ 2.3, Expanding AI-driven Actions in the iQ App to Improve Compliance and Labour Effectiveness for Hospitality Operators

    January 16, 2026

    Fourth, the leading provider of workforce and inventory management solutions for the hospitality sector, announces the release of Fourth iQ 2.3, delivering new AI-driven actions to help managers stay compliant and improve the effectiveness of their labour deployment. The update further expands a rapidly growing set of AI-driven actions within the Fourth iQ app across [...]

  • New Cloudflare Report Warns of a ‘Technical Glass Ceiling’ Stifling AI Growth and Weakening Cybersecurity

    January 16, 2026

    New research shows that organizations modernizing apps are 3x more likely to see AI payoffs, while those clinging to legacy systems face rising security risks and developer talent shortages

  • 500 Global Announces Promotion of Mei Chel Tan to Global Managing Partner

    January 16, 2026

    Appointment reflects expanding demand for entrepreneurial ecosystem development and AI readiness across emerging markets.

  • Paysafe Research: First-Time and Casual Betting to Surge for 2026 World Cup

    January 16, 2026

    60% of World Cup fans plan to bet online, marking a major revenue opportunity for online sportsbooks with optimized payments tailored to local preferences

  • Kikin Financial Announces $20 Million Debt Facility to Power Growth of UK Business

    January 16, 2026

    Kikin Financial, the UK-based fintech lending platform for SMEs, today announced it has secured initial funding through Percent’s platform, with capacity to access up to $20 million as Kikin scales. The funds will be used to provide flexible credit to some of the UK’s most exciting consumer businesses. Kikin’s innovative lending platform uses AI to [...]

  • Accertify Appoints CEO and Expands Executive Team to Fuel Next Phase of Growth

    January 16, 2026

    Greg Dukat appointed CEO as Accertify builds leadership depth to accelerate go-to-market execution

  • Barrows Connected Store Appoints James Hay as Global CEO

    January 16, 2026

    Barrows Connected Store, a global leader in connected retail experiences, today announced the appointment of James Hay as Global Chief Executive Officer, effective January 1, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114778548/en/ In his new role, Hay will lead the global Barrows Connected Store business, encompassing teams in the UK, [...]

  • Sixth Street Raises €3.75 Billion for Third European Direct Lending Fund

    January 16, 2026

    Sixth Street SLE III Hits Hard Cap, Reflecting Long-Term Strength as One of Europe’s Leading Private Capital Platforms

  • WRITER Appoints Mina Alaghband as First Chief Customer Officer to Accelerate Enterprise Transformation with Agentic AI

    January 16, 2026

    Alaghband will lead global customer operations as demand intensifies among Fortune 500 organizations for agentic platforms that accelerate business impact and deliver ROI at scale

  • Almirall Presents R&D Pipeline Advances Supported by Sustained Growth and Leadership in Medical Dermatology at J.P. Morgan Healthcare Conference

    January 16, 2026

    Pipeline advances in 2026 span a range of dermatology disease areas, including atopic dermatitis, hidradenitis suppurativa, and alopecia areata, with 3 ongoing PoC/Phase II clinical studies* and 3 additional studies to be initiated in 2026. Almirall’s sustained trajectory of growth and profitability enables the company to reach more patients and supports a growth outlook of double-digit net sales through 2030, combined biologics peak sales of approximately €800 MM (Ebglyss® and Ilumetri®), and a 25% EBITDA margin by 2028. Almirall's leadership in medical dermatology, biologics growth, and continued strong performance of its broad product portfolio fuel advancement of a diversified and innovative R&D pipeline addressing skin diseases with high unmet need.

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 176
  • Page 177
  • Page 178
  • Page 179
  • Page 180
  • …
  • Page 228
  • Next

Trending Articles

  • Andy Burnham hints at tax rises in Autumn Budget

  • Brewdog founder James Watt hits out at ‘total silence’ over new venture

  • Budget 2026: Which taxes will Burnham and Healey hike?

  • Lloyds Bank and Halifax users unable to use app in latest outage

  • Economists urge Bank of England to halt bond sales as borrowing costs climb

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook